Aarthi Anand, MD | UniHealth

Offices

1 location · South County Community Health Center Inc · 20 clinicians in this group

Looking this up.

Hospitals listed: Stanford Health Care. That is not proof they admit you there this week.

Plans that list them

25 plans · 7 carriers

A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Anand’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.

25 of 25 plans

Sort by

Plans whose provider directory lists this clinician

Alignment Health BreathEasy (HMO C-SNP)	Alignment Health Plan	Listed	Oct 3, 2026
Alignment Health Clarity (HMO C-SNP)	Alignment Health Plan	Listed	Oct 3, 2026
Alignment Health Harmony (HMO)	Alignment Health Plan	Listed	Oct 3, 2026
Alignment Health Heart & Diabetes (HMO C-SNP)	Alignment Health Plan	Listed	Oct 3, 2026
Alignment Health Heart & Diabetes CalPlus (HMO C-SNP)	Alignment Health Plan	Listed	Oct 3, 2026
Alignment Health Heart & Diabetes Care (HMO C-SNP)	Alignment Health Plan	Listed	Sep 28, 2026
Alignment Health Heart & Diabetes Choice (HMO C-SNP)	Alignment Health Plan	Listed	Sep 28, 2026
Alignment Health Honor+ Plan (HMO)	Alignment Health Plan	Listed	Oct 3, 2026
Alignment Health My Choice CalCare (HMO)	Alignment Health Plan	Listed	Oct 3, 2026
Alignment Health Silicon (HMO C-SNP)	Alignment Health Plan	Listed	Oct 3, 2026
Alignment Health smartHMO (HMO)	Alignment Health Plan	Listed	Oct 3, 2026
Alignment Health the ONE (HMO)	Alignment Health Plan	Listed	Oct 3, 2026
Anthem Full Dual Advantage Aligned (HMO D-SNP)	Anthem Blue Cross	Listed	Oct 3, 2026
Anthem Medicare Advantage (HMO-POS)	Anthem Blue Cross	Listed	Oct 3, 2026
Anthem Prime (HMO-POS)	Anthem Blue Cross Partnership Plan	Listed	Oct 3, 2026
Blue Shield Inspire (HMO)	Blue Shield of California	Listed	Aug 26, 2026
Central Health Classic Care Plan III (HMO)	Central Health Medicare Plan	Listed	Aug 15, 2026
Central Health Dual Access Plan (HMO D-SNP)	Central Health Medicare Plan	Listed	Aug 15, 2026
Central Health Embrace Choice Plan (HMO C-SNP)	Central Health Medicare Plan	Listed	Aug 15, 2026
Central Health Valor Care Plan (HMO)	Central Health Medicare Plan	Listed	Aug 15, 2026
SCAN Balance (HMO C-SNP)	SCAN Health Plan	Listed	Oct 3, 2026
SCAN Classic (HMO)	SCAN Health Plan	Listed	Oct 3, 2026
SCAN MyChoice (HMO)	SCAN Health Plan	Listed	Oct 3, 2026
SCAN Strive (HMO C-SNP)	SCAN Health Plan	Listed	Oct 3, 2026
AARP Medicare Advantage from UHC CA-10 (HMO-POS)	UnitedHealthcare	Listed, may be out of date	Jun 10, 2026

California Medical Board record

Licence A95944 · Current

Licensed to practise in California · since 2006 · expires 2027-08-31 · Dr. M.G.R. Medical University, P.S.G. Institute of Medical Sciences.

No disciplinary actions, convictions, malpractice judgments or citations in this record.

State licence records

1 licence

Illinois 036112184Licensed Physician And Surgeon · since 2004 · expires 2008-07-31
Not RenewedNo board action on this licenceCheck it with the state

We check Colorado, Delaware, Florida, Illinois, Maryland, New Jersey, New York, Tennessee, Texas, Virginia, Washington, plus California above. A state that is not in this list has not been checked, which is not the same as clear.

Hospitals they work in

1 hospital

These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.

Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend it
Overall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024

See every measure and the patient survey for Stanford Health Care

Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.

Sort by

Every scored measure at Stanford Health Care

Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths	5.31 (4.24 to 6.37) · 8,661 cases	Worse	Jul 2022 – Jun 2024
Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits	14.1 (12.7 to 15.7) · 2,191 cases	Worse	Jan 2024 – Dec 2024
Postoperative respiratory failure rateComplications and deaths	4.08 (1.95 to 6.21) · 5,296 cases	Better	Jul 2022 – Jun 2024
Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections	0.317	Better	Oct 2024 – Sep 2025
Clostridium Difficile (C.Diff)Infections	0.446	Better	Oct 2024 – Sep 2025
SSI - Colon SurgeryInfections	0.241	Better	Oct 2024 – Sep 2025
Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits	0.7 (0.6 to 0.9) · 3,348 cases	Better	Jan 2024 – Dec 2024
Abdominopelvic accidental puncture or laceration rateComplications and deaths	1.06 (0.45 to 1.67) · 5,374 cases	No different	Jul 2022 – Jun 2024
CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths	0.86 (0.72 to 1)	No different	Jul 2022 – Jun 2024
Death rate among surgical inpatients with serious treatable complicationsComplications and deaths	166.09 (137.88 to 194.3) · 470 cases	No different	Jul 2022 – Jun 2024
Death rate for CABG surgery patientsComplications and deaths	1.1 · 192 cases	None	Jul 2022 – Jun 2025
Death rate for COPD patientsComplications and deaths	6.4 · 146 cases	None	Jul 2022 – Jun 2025
Death rate for heart attack patientsComplications and deaths	9.7 · 253 cases	None	Jul 2022 – Jun 2025
Death rate for heart failure patientsComplications and deaths	6.3 · 880 cases	None	Jul 2022 – Jun 2025
Death rate for pneumonia patientsComplications and deaths	10.3 · 935 cases	None	Jul 2022 – Jun 2025
Death rate for stroke patientsComplications and deaths	8.7 · 501 cases	None	Jul 2023 – Jun 2025
Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths	2.1 · 7,730 cases	None	Jul 2024 – Jun 2025
Iatrogenic pneumothorax rateComplications and deaths	0.13 (0 to 0.27) · 20,799 cases	No different	Jul 2022 – Jun 2024
In-hospital fall-associated fracture rateComplications and deaths	0.28 (0.14 to 0.43) · 23,182 cases	No different	Jul 2022 – Jun 2024
Postoperative acute kidney injury requiring dialysis rateComplications and deaths	0.94 (0.2 to 1.68) · 5,694 cases	No different	Jul 2022 – Jun 2024
Postoperative hemorrhage or hematoma rateComplications and deaths	2.36 (1.54 to 3.19) · 7,846 cases	No different	Jul 2022 – Jun 2024
Postoperative sepsis rateComplications and deaths	5.2 (3.76 to 6.64) · 5,603 cases	No different	Jul 2022 – Jun 2024
Postoperative wound dehiscence rateComplications and deaths	1.38 (0.23 to 2.53) · 2,211 cases	No different	Jul 2022 – Jun 2024
Pressure ulcer rateComplications and deaths	0.52 (0.21 to 0.83) · 19,915 cases	No different	Jul 2022 – Jun 2024
Rate of complications for hip/knee replacement patientsComplications and deaths	3.6 · 416 cases	None	Apr 2023 – Mar 2025
Central Line Associated Bloodstream Infection (ICU + select Wards)Infections	0.869	No different	Oct 2024 – Sep 2025
MRSA BacteremiaInfections	0.857	No different	Oct 2024 – Sep 2025
SSI - Abdominal HysterectomyInfections	0.368	No different	Oct 2024 – Sep 2025
Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits	16.2 · 247 cases	None	Jul 2023 – Jun 2025
Heart failure (HF) 30-Day Readmission RateUnplanned return visits	20.5 · 1,021 cases	None	Jul 2023 – Jun 2025
Hospital return days for heart attack patientsUnplanned return visits	47.8 · 258 cases	None	Jul 2022 – Jun 2025
Hospital return days for heart failure patientsUnplanned return visits	-1.6 · 990 cases	None	Jul 2022 – Jun 2025
Hospital return days for pneumonia patientsUnplanned return visits	20.8 · 976 cases	None	Jul 2022 – Jun 2025
Pneumonia (PN) 30-Day Readmission RateUnplanned return visits	16.5 · 959 cases	None	Jul 2023 – Jun 2025
Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits	5.2 (4.4 to 6.2) · 2,191 cases	No different	Jan 2024 – Dec 2024
Rate of readmission after hip/knee replacementUnplanned return visits	5.1 · 425 cases	None	Jul 2023 – Jun 2025
Rate of readmission for CABGUnplanned return visits	9.6 · 158 cases	None	Jul 2023 – Jun 2025
Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits	19.6 · 183 cases	None	Jul 2023 – Jun 2025
Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits	12.7 (10.4 to 15.4) · 4,578 cases	No different	Jan 2022 – Dec 2024

What patients said (6,810 patients answered, 25% of those asked)

Sort by

Patient survey stars by topic at Stanford Health Care

Cleanliness	4
Nurse communication	4
Doctor communication	4
Communication about medicines	3
Discharge information	4
Overall hospital rating	4
Quietness	2
Recommend hospital	5

Sort by

Share of patients giving the best answer at Stanford Health Care

Room was "always" clean	75%
Nurses "always" communicated well	82%
Doctors "always" communicated well	81%
Staff "always" explained	63%
Yes, staff "did" give patients this information	89%
Yes, staff "did" give patients information about help after discharge	89%
Doctors "always" explained things so they could understand	76%
Doctors "always" listened carefully	80%
Doctors "always" treated them with courtesy and respect	87%
Patients who gave a rating of "9" or "10" (high)	79%
Staff "always" explained new medications	76%
Nurses "always" explained things so they could understand	77%
Nurses "always" listened carefully	79%
Nurses "always" treated them with courtesy and respect	88%
"Always" quiet at night	53%
"YES", patients would definitely recommend the hospital	83%
Staff "always" explained possible side effects	50%
Yes, staff "did" give patients information about possible symptoms	90%

Medicaid work

$388,460 in 2024

Medicaid paid $388,460 for 8,547 billed services this clinician did in 2024, up to 114 people in a month for one service.

Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.

Sort by

Largest Medicaid services in 2024

Clinic visit/encounter, all-inclusive	927	$356,982
Short return visit (20+ min)	1,539	$18,513
Return visit (30+ min)	298	$4,607
Hepatitis B vaccine (HepB), adult dosage, 3 dose schedule, for intramuscular use	129	$2,282
Screening for depression is documented as negative, a follow-up plan is not required	556	$2,237
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid)	562	$1,645
Zoster (shingles) vaccine (HZV), recombinant, subunit, adjuvanted, for intramuscular use	15	$720
Alcohol and/or drug screening	286	$449
Immunization administration by intramuscular injection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) vaccine, single dose	40	$320
Influenza virus vaccine, trivalent (IIV3), split virus, 0.5 mL dosage, for intramuscular use	45	$230
Influenza virus vaccine, trivalent (IIV3), split virus, preservative free, 0.5 mL dosage, for intramuscular use	47	$182
Screening for depression is documented as being positive and a follow-up plan is documented	22	$90

Sort by

Medicaid work by year

2024	8,547	25	114	$388,460
2023	8,103	22	162	$505,745
2022	8,797	19	203	$547,580
2021	14,683	30	371	$1,081,660
2020	2,357	9	101	$236,606
2019	1,671	9	90	$68,241

See the largest Medicaid services in earlier years

2023

Sort by

Largest Medicaid services in 2023

Clinic visit/encounter, all-inclusive	1,344	$490,563
Short return visit (20+ min)	1,788	$6,207
New patient visit (30+ min)	248	$3,110
Screening for depression is documented as negative, a follow-up plan is not required	642	$1,458
Return visit (30+ min)	288	$1,137
Zoster (shingles) vaccine (HZV), recombinant, subunit, adjuvanted, for intramuscular use	15	$880
Hepatitis B vaccine (HepB), adult dosage, 3 dose schedule, for intramuscular use	55	$658
Alcohol and/or drug screening	480	$542
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid)	493	$359
Tetanus, diphtheria toxoids and acellular pertussis vaccine (Tdap), when administered to individuals 7 years or older, for intramuscular use	21	$292
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); each additional vaccine (single or combination vaccine/toxoid) (List separately in addition to code for primary procedure)	42	$150
Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use	74	$126

2022

Sort by

Largest Medicaid services in 2022

Clinic visit/encounter, all-inclusive	1,497	$537,625
Short return visit (20+ min)	2,304	$6,677
Screening for depression is documented as negative, a follow-up plan is not required	811	$1,395
Return visit (30+ min)	136	$496
Alcohol and/or drug screening	610	$440
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid)	442	$243
Short return visit	78	$219
Influenza virus vaccine, quadrivalent (ccIIV4), derived from cell cultures, subunit, antibiotic free, 0.5 mL dosage, for intramuscular use	47	$179
New patient visit (30+ min)	38	$177
Screening for depression is documented as being positive and a follow-up plan is documented	19	$89
Handling and/or conveyance of specimen for transfer from physician office to laboratory	288	$39
BODY MASS INDEX DOCD	730	$0

2021

Sort by

Largest Medicaid services in 2021

Clinic visit/encounter, all-inclusive	2,992	$1,057,353
Short return visit (20+ min)	4,042	$14,210
Screening for depression is documented as negative, a follow-up plan is not required	1,475	$2,390
Zoster (shingles) vaccine (HZV), recombinant, subunit, adjuvanted, for intramuscular use	26	$1,192
Return visit (30+ min)	183	$941
Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; adolescent (age 12 through 17 years)	73	$859
New patient visit (30+ min)	83	$816
Short return visit	232	$742
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid)	762	$535
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); each additional vaccine (single or combination vaccine/toxoid) (List separately in addition to code for primary procedure)	133	$319
Screening test, pure tone, air only	146	$319
Periodic comprehensive preventive medicine reevaluation and management of an individual including an age and gender appropriate history, examination, counseling/anticipatory guidance/risk factor reduction interventions, and the ordering of laboratory/diagnostic procedures, established patient; 18-39 years	23	$309

2020

Sort by

Largest Medicaid services in 2020

Clinic visit/encounter, all-inclusive	830	$233,717
Short return visit (20+ min)	802	$2,401
Screening for depression is documented as negative, a follow-up plan is not required	206	$205
OFFICE/OUTPATIENT NEW SF MDM 15 MINUTES	47	$202
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid)	90	$45
Handling and/or conveyance of specimen for transfer from physician office to laboratory	253	$36
BODY MASS INDEX DOCD	48	$0
OFF/OP EST MAY X REQ PHY/QHP	21	$0
Short return visit	60	$0

2019

Sort by

Largest Medicaid services in 2019

Clinic visit/encounter, all-inclusive	530	$66,304
Short return visit (20+ min)	556	$1,647
Tetanus, diphtheria toxoids and acellular pertussis vaccine (Tdap), when administered to individuals 7 years or older, for intramuscular use	17	$120
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid)	169	$77
Handling and/or conveyance of specimen for transfer from physician office to laboratory	218	$60
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); each additional vaccine (single or combination vaccine/toxoid) (List separately in addition to code for primary procedure)	47	$32
COLLECTION VENOUS BLOOD VENIPUNCTURE	79	$0
Blood count; complete (CBC), automated (Hgb, Hct, RBC, WBC and platelet count)	12	$0
Influenza virus vaccine, quadrivalent (IIV4), split virus, 0.5 mL dosage, for intramuscular use	43	$0

Drugs they prescribed that Part D paid

$85,636

Pharmacies billed $85,636 in 2024.

This is pharmacy cost, not the office bill, and not what patients paid.

812 generic and 91 brand-name prescriptions · $85,636 in drug cost.

Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.

Sort by

Largest Part D drug costs

Eliquis	16	$22,549	$1,409
Ozempic	11	$10,326	$939
Gabapentin	29	$594	$20
Atorvastatin	83	$543	$7
Losartan	61	$451	$7

See all 26 drugs

Sort by

Every Part D drug this clinician prescribed

Eliquis	16	$22,549	$1,409
Ozempic	11	$10,326	$939
Gabapentin	29	$594	$20
Atorvastatin	83	$543	$7
Losartan	61	$451	$7
Metoprolol	31	$422	$14
Amlodipine Besylate	88	$284	$3
Losartan-Hydrochlorothiazide	12	$271	$23
Levothyroxine	26	$263	$10
Lisinopril	40	$234	$6
Pantoprazole	23	$228	$10
Rosuvastatin	15	$218	$15
Omeprazole	21	$217	$10
Alendronate	34	$183	$5
Simvastatin	18	$176	$10
Diclofenac	15	$172	$11
Tamsulosin	21	$156	$7
Finasteride	14	$141	$10
Metformin	24	$136	$6
Clopidogrel	11	$123	$11
Bumetanide	11	$107	$10
Escitalopram	13	$92	$7
Fluticasone Propionate	11	$74	$7
Sertraline	17	$70	$4
Hydrochlorothiazide	12	$24	$2
Metoprolol	15	$23	$2

Year by year

Sort by

Part D prescribing by year

2024	914	91	None	10%	$85,636
2023	733	70	0% (0)	None	$57,690
2022	720	68	0% (0)	None	$49,371
2021	695	76	None	10%	$47,720
2020	697	52	0% (0)	None	$28,349
2019	423	53	0% (0)	None	$21,252
2018	183	42	None	30%	$14,540
2017	86	14	None	64%	$11,960
2016	220	31	10% (22)	None	$11,423
2015	356	44	9% (32)	17%	$16,667
2014	1,240	96	2% (23)	22%	$98,537
2013	864	73	None	None	$49,016

Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.

See the drugs prescribed each year

2023: 15 drugs

Sort by

Part D drugs prescribed in 2023

Atorvastatin	77	$1,656	$22
Losartan	62	$1,173	$19
Amlodipine Besylate	72	$1,142	$16
Metoprolol	37	$814	$22
Lisinopril	43	$603	$14
Tamsulosin	19	$587	$31
Omeprazole	24	$549	$23
Metformin	31	$471	$15
Levothyroxine	21	$369	$18
Alendronate	21	$334	$16
Sertraline	13	$284	$22
Gabapentin	17	$282	$17
Simvastatin	16	$186	$12
Clopidogrel	13	$106	$8
Furosemide	11	$83	$8

2022: 16 drugs

Sort by

Part D drugs prescribed in 2022

Sucralfate	14	$2,002	$143
Atorvastatin	73	$1,508	$21
Losartan	66	$944	$14
Metoprolol	42	$895	$21
Amlodipine Besylate	73	$868	$12
Rosuvastatin	15	$706	$47
Gabapentin	25	$530	$21
Levothyroxine	22	$428	$19
Metformin	41	$415	$10
Lisinopril	33	$343	$10
Omeprazole	22	$288	$13
Tamsulosin	16	$259	$16
Alendronate	22	$159	$7
Simvastatin	19	$108	$6
Sertraline	16	$82	$5
Hydrochlorothiazide	14	$77	$5

2021: 15 drugs

Sort by

Part D drugs prescribed in 2021

Levothyroxine	40	$744	$19
Atorvastatin	67	$686	$10
Metoprolol	29	$599	$21
Amlodipine Besylate	52	$407	$8
Losartan	44	$400	$9
Valsartan-Hydrochlorothiazide	11	$377	$34
Lisinopril	44	$334	$8
Pravastatin	16	$316	$20
Omeprazole	24	$314	$13
Metformin	36	$277	$8
Gabapentin	17	$216	$13
Simvastatin	22	$151	$7
Metoprolol	14	$122	$9
Glipizide	11	$90	$8
Hydrochlorothiazide	18	$72	$4

2020: 16 drugs

Sort by

Part D drugs prescribed in 2020

Xarelto	11	$11,935	$1,085
Atorvastatin	63	$655	$10
Levothyroxine	28	$616	$22
Metoprolol	38	$500	$13
Losartan	39	$487	$12
Amlodipine Besylate	69	$324	$5
Lisinopril	45	$207	$5
Pravastatin	11	$171	$16
Metformin	35	$167	$5
Omeprazole	16	$162	$10
Clopidogrel	11	$152	$14
Simvastatin	30	$149	$5
Citalopram Hbr	16	$145	$9
Finasteride	12	$138	$11
Ibuprofen	16	$106	$7
Hydrochlorothiazide	17	$61	$4

2019: 11 drugs

Sort by

Part D drugs prescribed in 2019

Spiriva	18	$4,967	$276
Citalopram Hbr	14	$635	$45
Atenolol	16	$574	$36
Atorvastatin	34	$478	$14
Levothyroxine	20	$356	$18
Amlodipine Besylate	47	$293	$6
Metoprolol	11	$268	$24
Losartan	28	$210	$7
Pravastatin	12	$174	$15
Metformin	19	$156	$8
Lisinopril	16	$96	$6

2018: 3 drugs

Sort by

Part D drugs prescribed in 2018

Spiriva	15	$5,710	$381
Humulin N	15	$2,764	$184
Amlodipine Besylate	17	$191	$11

2017: 4 drugs

Sort by

Part D drugs prescribed in 2017

Advair Diskus	14	$5,117	$366
Fenofibrate	12	$314	$26
Levothyroxine	12	$182	$15
Pantoprazole	12	$77	$6

2016: 5 drugs

Sort by

Part D drugs prescribed in 2016

Fenofibrate	11	$589	$54
Lisinopril	15	$91	$6
Metoprolol	13	$68	$5
Warfarin	14	$52	$4
Furosemide	14	$37	$3

2015: 6 drugs

Sort by

Part D drugs prescribed in 2015

Warfarin	83	$489	$6
Atorvastatin	31	$335	$11
Furosemide	25	$162	$6
Carvedilol	13	$160	$12
Omeprazole	11	$101	$9
Lisinopril	11	$39	$4

2014: 32 drugs

Sort by

Part D drugs prescribed in 2014

Humira	11	$28,971	$2,634
Januvia	14	$5,884	$420
Lantus Solostar	19	$5,806	$306
Diovan	21	$4,398	$209
Nexium	18	$4,374	$243
Advair Diskus	14	$4,056	$290
Janumet	11	$3,288	$299
Valsartan-Hydrochlorothiazide	37	$1,839	$50
Nasonex	11	$1,829	$166
Atorvastatin	136	$1,589	$12
Metoprolol	57	$1,258	$22
Metformin	78	$539	$7
Pravastatin	25	$480	$19
Omeprazole	47	$385	$8
Amlodipine Besylate	92	$374	$4
Levothyroxine	30	$345	$11
Clopidogrel	20	$285	$14
Lisinopril	46	$246	$5
Lisinopril-Hydrochlorothiazide	36	$199	$6
Tamsulosin	15	$193	$13
Zolpidem	17	$179	$11
Enalapril Maleate	22	$164	$7
Metoprolol	27	$147	$5
Alendronate	21	$131	$6
Donepezil	11	$128	$12
Gabapentin	20	$108	$5
Simvastatin	16	$97	$6
Pantoprazole	15	$95	$6
Carvedilol	12	$90	$7
Allopurinol	12	$77	$6
Meloxicam	13	$73	$6
Losartan	11	$64	$6

2013: 24 drugs

Sort by

Part D drugs prescribed in 2013

Januvia	22	$7,245	$329
Advair Diskus	17	$5,589	$329
Crestor	24	$4,145	$173
Nexium	11	$2,477	$225
Exforge	11	$2,022	$184
Valsartan-Hydrochlorothiazide	21	$1,561	$74
Atorvastatin	64	$1,264	$20
Metoprolol	33	$693	$21
Metformin	80	$645	$8
Omeprazole	32	$374	$12
Lisinopril	46	$306	$7
Losartan-Hydrochlorothiazide	17	$277	$16
Amlodipine Besylate	49	$267	$5
Chlorthalidone	14	$236	$17
Levetiracetam	11	$231	$21
Meclizine	12	$230	$19
Pantoprazole	19	$196	$10
Levothyroxine	23	$170	$7
Carvedilol	19	$145	$8
Alendronate	18	$117	$7
Enalapril Maleate	15	$90	$6
Simvastatin	12	$90	$7
Ibuprofen	16	$88	$6
Lisinopril-Hydrochlorothiazide	12	$81	$7

Money from drug and device companies

$53 in 2019

A payment is not proof that care is biased.

Sort by

Payments by company

Merck Sharp & Dohme	Nexplanon	$53	1 payment Meals for Nexplanon · 2019-08-13 · $53

See the published payment

Sort by

Every published payment

Merck Sharp & Dohme	Meals · 2019-08-13	Nexplanon	$53

Professional record

NPI: 1881776060
Licence: CA A95944, CT 045919, IL 36112184California A95944: Current · expires 2027-08-31Illinois 036112184: Not Renewed
Group: South County Community Health Center Inc
Gender: Female

More record details

Sole proprietor: No
Taxonomy: Federal specialty code 207QG0300X (207QG0300X)
Mailing address: 270 Grant Ave, Palo Alto, CA, 94306
NPI first listed: 2006-10-19
NPI last updated: 2025-10-15
NPI record certified: 2025-10-15

This is when the NPI record was last certified, not a medical board exam.